Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Apoptosis in liver disease.

M Schuchmann¹, P R Galle

¹Department of Internal Medicine I, Johannes Gutenberg University, Mainz, Germany.

European Journal of Gastroenterology & Hepatology

|July 28, 2001

Summary

Apoptosis, a controlled cell death process, is crucial for tissue health. Dysregulation of apoptosis contributes to liver diseases, involving specific cell receptors and caspases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinoma.

ESMO open·2025

Same author

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Same author

Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care.

PloS one·2021

Same author

Role of immunotherapy in the management of hepatocellular carcinoma: current standards and future directions.

Current oncology (Toronto, Ont.)·2020

Same author

Hepatitis E Is a Rare Finding in Liver Transplant Patients With Chronic Elevated Liver Enzymes and Biopsy-Proven Acute Rejection.

Transplantation proceedings·2020

Same author

A Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma.

Clinical and translational gastroenterology·2019

Area of Science:

Molecular Biology
Cell Biology
Pathology

Background:

Extracellular signals regulate biological functions, including growth control by growth factors.
Cell death, or apoptosis, is a highly controlled process vital for development, immune regulation, and tissue homeostasis.
Aberrant apoptosis is increasingly implicated in various diseases, notably liver diseases.

Purpose of the Study:

To review the mechanisms underlying the derangement of the apoptotic program in liver diseases.
To highlight the role of specific cell death pathways in liver pathology.

Main Methods:

Review of existing literature on apoptosis, cell death receptors, and caspases.
Focus on the molecular mechanisms initiating apoptosis via receptors like CD95 (Fas).
Analysis of how caspase activation leads to cellular destruction.

Main Results:

Apoptosis is initiated by ligand binding to membrane receptors, such as CD95 (Fas) from the TNF receptor superfamily.
Activated caspases form the core intracellular machinery, orchestrating cellular dismantling.
Disruption of this tightly regulated apoptotic program is a key factor in liver disease pathogenesis.

Conclusions:

The apoptotic pathway is a critical target for understanding and potentially treating liver diseases.
Understanding the molecular basis of apoptosis dysregulation is essential for addressing liver pathologies.
Further research into the specific mechanisms of apoptosis derangement in liver disease is warranted.

Related Experiment Videos